Virano Therapeutics
A genetic immunomodulation company developing next-generation combination therapeutic products that reprogram immune responses to treat solid tumors and genetic diseases by combining immune-modulating small molecules with gene delivery and biological therapeutic elements.
Industries
biotechnology
Nr. of Employees
small (1-50)
Products
Combination therapeutic candidates integrating immune-modulating small molecules with gene delivery and biological therapeutics
Development of next-generation combination products that combine immune‑modulating small molecules with gene delivery systems and biological therapeutic elements to treat solid tumors and genetic diseases.
Combination therapeutic candidates integrating immune-modulating small molecules with gene delivery and biological therapeutics
Development of next-generation combination products that combine immune‑modulating small molecules with gene delivery systems and biological therapeutic elements to treat solid tumors and genetic diseases.
Expertise Areas
- Genetic immunomodulation
- Combination therapeutic development
- Oncology therapeutics (solid tumors)
- Gene delivery
Key Technologies
- Gene delivery systems
- Small-molecule immunomodulators
- Combination therapeutic platforms
- Biologic therapeutics